NFJ Short Volume
Virtus Dividend, Interest & Premium Strategy Fund (NFJ) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $1.42B, listed on NYSE, carrying a beta of 1.10 to the broader market. AllianzGI NFJ Dividend, Interest & Premium Strategy Fund is a closed ended equity mutual fund launched and managed by Allianz Global Investors Fund Management LLC. Led by George Robert Aylward, public since 2005-03-01.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-07-16
- Short Volume
- 65.0K
- Total Volume
- 129.7K
- Short %
- 50.10%
- 30-Day Avg Short %
- 43.96%
Showing 30 days of FINRA short volume data for Virtus Dividend, Interest & Premium Strategy Fund.
Learn how short volume is reported and how to read the data →
Frequently asked NFJ short volume questions
- What is the daily NFJ short volume?
- As of Jul 16, 2026, Virtus Dividend, Interest & Premium Strategy Fund (NFJ) short volume is 65.0K shares against 129.7K total reported volume, or 50.10% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is NFJ short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does NFJ short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.